DRCR.Net Aflibercept vs. Bevacizumab + Deferred Aflibercept for the Treatment of CI-DME

NCT03321513 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

270

Enrollment

OTHER

Sponsor class

Conditions

Diabetic Macular Edema

Interventions

DRUG: intravitreous aflibercept
DRUG: Bevacizumab + Deferred Aflibercept Group

Sponsor

Jaeb Center for Health Research